8th Annual Chief Medical Officer Summit

The 8th annual Chief Medical Officer Summit will attract the largest gathering of physicians in biotech on April 6-7, 2020 in Boston. Although the program is primarily designed for CMOs of emerging biotech companies, large pharma CMOs and other R&D decision-makers also attend to exchange best practices in drug development and business management.

Key Topic Areas for 2020

• The Collective Struggle to Evolve a Drug Development Organization’s Data and Analytics Culture and Capabilities
• The Evolving Role of a CMO from Pre- to Post-IPO
• Recruiting, Retaining and Motivating Top-Level Talent
• New Skills Required for CMOs
• Navigating the Pricing and Reimbursement Environment
• Insourcing and Outsourcing as Your Company Evolves
• Prioritizing Effectively: How to Serve What Seems Like Everybody in the CMO Role
• The Changing R&D Landscape in the Biotech and Pharmaceutical Industry
• Harmonizing Drug Development and Clinical Operations Across Different Continents and Countries
• Building Teams and Expanding Your Reach with Virtualization

Dedicated to Accomplishing Two Goals

1. To bring together CMO and R&D executives to address the unique challenges associated with directing and managing all R&D functions with limited resources, while raising capital and strategizing for appropriate exits.
2. To create a network of CMOs and R&D Leadership from small to mid-size life science companies to share ideas, solutions and support.